throbber

`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`FRESENIUS KABI USA, LLC and FRESENIUS KABI SWISSBIOSIM GmbH
`Petitioners,
`
`v.
`
`AMGEN, INC. and AMGEN MANUFACTURING LIMITED
`Patent Owners.
`
`
`IPR2020-00314
`
`Patent No. 9,856,287
`
`Title: REFOLDING PROTEINS USING A CHEMICALLY CONTROLLED
`REDOX STATE
`
`
`UPDATED EXHIBIT LIST
`
`
`
`

`

`UPDATED LIST OF EXHIBITS
`
`EXHIBIT NO.
`
`DESCRIPTION
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`
`
`United States Patent No. 9,856,287
`
`Declaration of Professor Paul A. Dalby, Ph.D.
`
`United States Patent No. 4,237,224
`
`United States Patent No. 4,468,464
`
`United States Patent No. 4,740,470
`
`Curriculum Vitae of Professor Paul A. Dalby, Ph.D.
`De Bernardez Clark, E. et al., “Oxidative Renaturation of Hen
`Egg-White Lysozyme. Folding vs Aggregation,” Biotechnology
`Progress 14(1):47-54 (1998)
`De Bernardez Clark, E., “Protein refolding for industrial
`processes,” Current Opinion in Biotechnology 12(2):202-07
`(April 2001)
`Ejima, D. et al., “High Yield Refolding and Purification Process
`for Recombinant Human Interleukin-6 Expressed in Escherichia
`coli,” Biotechnology and Bioengineering, 62(3):301-10
`(February 1999)
`Excerpts of United States Patent No. 9,856,287 File History
`Ferrer-Miralles, N. et al., “Microbial factories for recombinant
`pharmaceuticals,” Microbial Cell Factories 8:17 (2009)
`Georgiou, G. & Valax, P., “Isolating Inclusion Bodies from
`Bacteria,” Methods in Enzymology 309:48-58 (1999)
`Gilbert, H., “Molecular and Cellular Aspects of Thiol-Disulfide
`Exchange,” in Advances in Enzymology and Related Areas of
`Molecular Biology, ed. Alton Meister, Vol. 63, pp. 69-172 (John
`Wiley & Sons 1990)
`Gilbert, H., “Thiol/Disulfide Exchange Equilibria and Disulfide
`Bond Stability,” in Methods in Enzymology, ed. Lester Packer,
`Vol. 251, pp. 8-28 (Academic Press 1995)
`
`1
`
`

`

`EXHIBIT NO.
`
`1015
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`
`
`DESCRIPTION
`Graumann, K. & Premstaller, A., “Manufacturing of
`recombinant therapeutic proteins in microbial systems,”
`Biotechnology Journal 1:164-86 (2006)
`Hevehan, D, & Clark, E., “Oxidative Renaturation of Lysozyme
`at High Concentrations,” Biotechnology and Bioengineering,
`54(3):221-30 (May 1997)
`Horton, R. et al., Principles of Biochemistry ( Pearson
`Education, 4th ed., 2006)
`Jungbauer, A. & Kaar, W., “Current status of technical protein
`refolding,” Journal of Biotechnology 128:587-96 (2007)
`Keire, D. et al., “Kinetics and Equilibria of Thiol/Disulfide
`Interchange Reactions of Selected Biological Thiols and Related
`Molecules with Oxidized Glutathione,” J. Org. Chem. 57(1):123-
`27 (1992)
`Neubauer, P. et al., “Protein Inclusion Bodies in Recombinant
`Bacteria,” in Inclusions in Prokaryotes, ed. J.M. Shively, pp.
`237-92 (Springer-Verlag Berlin Heidelberg 2006)
`Palmer, I. & Wingfield, P., “Preparation and Extraction of
`Insoluble (Inclusion-Body) Proteins from Escherichia coli, Curr
`Protoc Protein Sci. Chapter: Unit-6.3 (November 2004)
`Panda, A., “Bioprocessing of Therapeutic Proteins from the
`Inclusion Bodies of Escherichia coli,” Adv Biochem
`Engin/Biotechnol 85:43-93 (2003)
`Patra, A. et al., “Optimization of Inclusion Body Solubilization
`and Renaturation of Recombinant Human Growth Hormone
`from Escherichia coli,” Protein Expression and Purification
`18:182-92 (2000)
`Profacgen, “Inclusion body purification & protein refolding,”
`accessed at https://www.profacgen.com/inclusion-body-
`purification-protein-refolding.htm
`International Publication No. WO 95/32216
`Ryan, R. et al., “Structure-Function Relationships of
`Gonadotropins,” in Recent Progress in Hormone Research, Vol.
`43, pp. 383-429 (Academic Press 1987)
`Schafer, F. & Buettner, G., “Redox Environment of the Cell as
`Viewed Through the Redox State of the Glutathione
`
`2
`
`

`

`EXHIBIT NO.
`
`1028
`
`1029
`
`1030
`
`1031
`
`1032
`
`1033
`
`1034
`
`1035
`
`1036
`
`1037
`
`1038
`
`1039
`
`1040
`
`1041
`
`1042
`
`
`
`DESCRIPTION
`Disulfide/Glutathione Couple,” Free Radical Biology &
`Medicine 30(11):1191-12 (June 2001)
`United States Patent Application Publication No. 2007/0238860
`Singh, S. & Panda, A., “Solubilization and Refolding of
`Bacterial Inclusion Body Proteins,” Journal of Bioscience and
`Bioengineering 99(4):303-10 (2005)
`Vallejo, L. & Rinas, U., “Strategies for the recovery of active
`proteins through refolding of bacterial inclusion body proteins,”
`Microbial Cell Factories 3:11 (2004)
`European Patent Application No. 1 449 848 A1, Method for the
`production of cystine-knot proteins (2004)
`Ventura, S. & Villaverde, A., “Protein quality in bacterial
`inclusion bodies,” Trends in Biotechnology 24(4):179-85 (April
`2006)
`Wetlaufer, D. et al., “The oxidative folding of proteins by
`disulfide plus thiol does not correlate with redox potential,”
`Protein Engineering 1(2):141-46 (1987)
`Whitford, D., Proteins: Structure and Function (John Wiley &
`Sons 2005)
`Peptides Guide, “What are Proteins?” accessed at
`http://www.peptidesguide.com/proteins.html
`Xie, Y. et al., “Recombinant Human Retinol-Binding Protein
`Refolding, Native Disulfide Formation, and Characterization,”
`Protein Expression and Purification 14:31-37 (1998)
`Patent Owner’s Preliminary Response Under 37 C.F.R. § 42.207,
`dated January 23, 2019
`Final Written Decision in IPR2016-01542, Patent 8,952,138,
`dated February 15, 2018
`Archer, D. et al., “Hen Egg White Lysozyme Expressed In, and
`Secreted from, Aspergillus Niger is Correctly Processed and
`Folded,” Bio/Technology 8:741-45 (August 1990)
`United States Patent No. 5,663,304
`
`United States Patent No. 8,952,138
`De Bernardez Clark, E., “Refolding of recombinant proteins,”
`Current Opinion in Biotechnology 9:157-63 (1998)
`
`3
`
`

`

`EXHIBIT NO.
`
`DESCRIPTION
`
`1043
`
`1044
`
`1045
`
`1046
`
`1047
`
`1048
`
`
`
`
`Atassi, M.Z., “Chemical Strategy for Studying the Antigenic
`Structures of Disulfide-Containing Proteins: Hen Egg-White
`Lysozyme as a Model,” in Protein Crosslinking, ed. M.
`Friedman, Vol. 6, pp. 89-137 (Plenum Press 1977)
`Table of categorized claims for United States Patent No.
`9,856,287
`“Glutathione” in The Merck Index, 12th Ed., pp. 4483-84 (Merck
`Research Laboratories 1996)
`Middleberg, A., “Preparative protein folding,” TRENDS in
`Biotechnology 20(10):437-43 (October 2002)
`Redline Petition IPR2019-00917/Petition IPR2020-000314
`
`Settlement Agreement [CONFIDENTIAL]
`
`
`
`
`
`4
`
`

`

`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that copies of Petitioners’ UPDATED
`
`EXHIBIT LIST and EXHIBIT 1048 have been served in their entirety by causing
`
`the aforementioned documents to be electronically mailed to the following
`
`attorneys of record for the Patent Owner listed below:
`
`Patent Owner's Counsel of Record:
`
`Megan Raymond (Reg. No. 72,997)
`mraymond@paulweiss.com
`
`J. Steven Baughman (Reg. No. 47,414)
`sbaughman@paulweiss.com
`
`
`
`
`
`Dated: June 18, 2020
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`By:
`
`
`/Huiya Wu/
`
`5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket